SG extends insurance coverage for COVID-19 vaccine complications

This is part of its continued support for the vaccination and booster drive.

The Life Insurance Association of Singapore (LIA Singapore) has announced that the insurance coverage of in-patient hospitalisation under Integrated Shield Plans (IP) for COVID-19 vaccination complications will be extended until 31 December 2022.

On the same basis as before, the extended coverage will apply to all IP policyholders who receive COVID-19 vaccines under the National Vaccination Programme as well as those approved by the World Health Organisation under its Emergency Use Listing Procedure and administered in Singapore under the Special Access Route. This initiative reflects the life insurance industry’s continued support of the government’s ongoing vaccination and booster immunisation programme.

The 12-month support given by all seven IP insurers was supposed to have ended on 31 December 2021.

“Life insurers remain committed to playing their part in the collective effort to bring COVID-19 under control by supporting the National Vaccination Programme. IP policyholders taking their vaccination and booster shots can rest assured that any related medical complications resulting in hospitalisation will be covered by their respective insurers,” LIA president Khor Hock Seng said.

The seven IP insurers in Singapore are AIA, AXA, Great Eastern Life, NTUC Income, Prudential Singapore, Raffles Health Insurance, and Singlife with Aviva.

Follow the link s for more news on

LIA Singapore

Insurance Cover For COVID-19 vaccine complications

Integrated Shield Plan

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia